Eligard and Hot flush - a phase IV clinical study of FDA data
Summary:
We study 36,493 people who have side effects when taking Eligard. Hot flush is found, especially among people who are 60+ old, have been taking the drug for 1 - 6 months, also take Xtandi and have Prostate cancer metastatic.
The phase IV clinical study analyzes which people take Eligard and have Hot flush. It is created by eHealthMe based on reports from the FDA, and is updated regularly. You may use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
36,493 people reported to have side effects when taking Eligard.
Among them, 6,180 people (16.93%) have Hot flush.
What is Eligard?
Eligard has active ingredients of leuprolide acetate. It is used in prostate cancer. Currently, eHealthMe is studying from 36,551 Eligard users.
What is Hot flush?
Hot flush (sudden feelings of heat) is found to be associated with 2,995 drugs and 2,294 conditions by eHealthMe. Currently, we are studying 84,471 people who have Hot flush.
Number of Eligard and Hot flush reports submitted per year:
Time on Eligard when people have Hot flush *:
Age of people who have Hot flush when taking Eligard *:
Common drugs people take besides Eligard *:
Common side effects people have besides Hot flush *:
Common conditions people have *:
* Approximation only. Some reports may have incomplete information.
Do you take Eligard and have Hot flush?
Check whether Hot flush is associated with a drug or a conditionHow to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related publications that referenced our studies
- Sharma SP, Muggia F, "Supraventricular tachycardia and urticaria complicating leuprolide-induced ovarian suppression in a young woman with breast cancer: a case report", ecancermedicalscience, 2016 Jan .
- Pong YH, Lu YC, Tsai VF, Huang PL, Hsieh JT, Chang HC, "Acute manic and psychotic symptoms following subcutaneous leuprolide acetate in a male patient without prior psychiatric history: A case report and literature review", Urological Science, 2014 Mar .
Related studies
Eligard side effects by duration, gender and age:
- Eligard side effects (36,551 reports)
Hot flush treatments and more:
- Hot flush (84,471 reports)
Common drugs associated with Hot flush:
- Eligard: 6,180 reports
- Lupron: 5,225 reports
- Lupron depot: 3,453 reports
- Aspirin: 3,444 reports
- Xtandi: 3,369 reports
- Tecfidera: 3,126 reports
- Prednisone: 2,759 reports
- Ibrance: 2,370 reports
- Vitamin d: 2,125 reports
- Synthroid: 2,103 reports
All the drugs that are associated with Hot flush:
- Hot flush (2,995 drugs)
Common conditions associated with Hot flush:
- Prostate cancer: 8,016 reports
- Multiple sclerosis: 5,253 reports
- Breast cancer: 2,588 reports
- Rheumatoid arthritis: 2,568 reports
- Endometriosis: 2,264 reports
- High blood pressure: 2,181 reports
- Pain: 1,995 reports
All the conditions that are associated with Hot flush:
- Hot flush (2,294 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on leuprolide acetate (the active ingredients of Eligard) and Eligard (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Clopra and Ilaris drug interaction - 8 seconds ago
- Acetaminophen and Generalised Erythema - 11 seconds ago
- Turmeric and Lonsurf drug interaction - 28 seconds ago
- Depo-Estradiol and High Blood Pressure - 30 seconds ago
- Yasmin and Nitrolingual drug interaction - 33 seconds ago
- Melatonin and Withdrawal Syndrome - 33 seconds ago
- Provera and Retinal Vessel Occlusion - 34 seconds ago
- Vesicare and Korlym drug interaction - 39 seconds ago
- Docetaxel and Lupron Depot drug interaction - 53 seconds ago
- Ketamine Hcl and Tremor - 55 seconds ago